Zobrazeno 1 - 10
of 53
pro vyhledávání: '"Matthew A. Sills"'
Publikováno v:
SLAS Discovery. 10:581-589
High-throughput screening (HTS) has grown rapidly in the past decade, with many advances in new assay formats, detection technologies, and laboratory automation. Recently, several studies have shown that the choice of assay technology used for the sc
Publikováno v:
SLAS Discovery. 5:23-30
In the last few years, fluorescence polarization (FP) has been applied to the development of robust, homogeneous, high throughput assays in molecular recognition research, such as ligand-protein interactions. Recently, this technology has been applie
Autor:
Matthew A. Sills
Publikováno v:
Drug Discovery Today. 3:304-312
Today, in the area of Biomolecular Screening, it would seem that `something better' in terms of instrumentation or assay technology, is emerging almost every week. From the standpoint of planning, this presents significant challenges to decide whethe
Publikováno v:
SLAS Discovery. 1:23-26
A solid-phase assay to evaluate interactions with the GRB-SH2 domain is described. The method is based on the binding of a radio-iodinated 13 amino acid phosphopeptide flanking Y1068 of the EGF receptor to the SH2 domain attached to the surface of a
Publikováno v:
Tetrahedron Letters. 35:6815-6818
A sponge of the genus Theonella collected off Perth, Australia, contained a cyclic octapeptide, perthamide B, which weakly inhibited the binding of [125I]IL-1β to intact EL4.6.1 cells with an IC50 of 27.6 μM. The inhibition of binding could however
Autor:
Matthew A. Sills
Publikováno v:
Drug Development Research. 32:260-268
In the drug discovery process, compounds that demonstrate therapeutic potential must be free of undesirable side effects in order to reach the clinic. Compounds that interact with more than one target, such as a receptor, have the potential to elicit
Autor:
Michelle Kelly-Borges, Donna R. Yarwood, Nanda K. Gulavita, Amy E. Wright, Matthew A. Sills, Ross E. Longley
Publikováno v:
Tetrahedron Letters. 35:4299-4302
A glycoside, which we call eryloside E ( 1 ), was isolated from the marine sponge Erylus goffrilleri and characterized by spectroscopic methods. Eryloside E possesses a rare penasterol nucleus with a t -butyl substituent on the side chain and three s
Autor:
D. Yarwood, Michelle Kelly-Borges, N. K. Gulavita, Matthew A. Sills, R. E. Longley, Amy E. Wright
Publikováno v:
ChemInform. 25
Publikováno v:
ChemInform. 26
A sponge of the genus Theonella collected off Perth, Australia, contained a cyclic octapeptide, perthamide B, which weakly inhibited the binding of [125I]IL-1β to intact EL4.6.1 cells with an IC50 of 27.6 μM. The inhibition of binding could however
Publikováno v:
Cardiovascular Drug Reviews. 10:26-53